¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022 ´ëÇѽŰæÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ ¹× Á¦6Â÷ ¼¼°è½Å°æÁ¾¾çÇÐȸ Çмú´ëȸ (1ÀÏÂ÷) : 2022-03-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022 ´ëÇѽŰæÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ ¹× Á¦6Â÷ ¼¼°è½Å°æÁ¾¾çÇÐȸ Çмú´ëȸ (1ÀÏÂ÷) : 2022-03-24
±³À°ÀÏÀÚ : 2022-03-24
±³À°Àå¼Ò : ¼­¿ï ÄÚ¿¢½º  
±³À°ÁÖÁ¦ : (¿Â-¿ÀÇÁº´Çà) 2022 ´ëÇѽŰæÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ ¹× Á¦6Â÷ ¼¼°è½Å°æÁ¾¾çÇÐȸ Çмú´ëȸ (1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¾¾çÇÐȸ(ÀÎ)
´ã´çÀÚ : »ç¹«±¹
¿¬¶ôó : 02-3452-0507  
À̸ÞÀÏ : office@wfnos2022.org      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú
Âü¼®¿¹»óÀοø : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 19 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 720,000¿ø      
ºñ°í WFNOSȸ¿ø±âÁØ »çÀüµî·Ï USD 500 / ÇöÀåµî·Ï USD 600      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-24 GBR 101+102, 1F 08:00~08:20 The trend of New WHO classification  David Capper(Charité University Germany) 
±³À°½Ã°£ 03-24 GBR 101+102, 1F 08:20~08:40 Update in New WHO Classification- Adult glioma-IDH-wildtype  Arie Perry(University of California San Francisco USA) 
±³À°½Ã°£ 03-24 GBR 101+102, 1F 08:40~09:00 Update in New WHO Classification - Adult glioma-IDH-mutant  Ho-Keung NG(Chinese University of Hong Kong Hong Kong) 
±³À°½Ã°£ 03-24 GBR 101~105 09:00~09:40 Glioma, cell of origin  Luis F. Parada(Memorial Sloan Kettering Cancer Center USA) 
±³À°½Ã°£ 03-24 GBR 101~105 09:40~10:20 New targets for cancer stem cells: redox regulation and differentiation  Hideyuki Saya(Keio University Japan) 
È޽Ġ03-24  10:20~10:40 Break  () 
±³À°½Ã°£ 03-24 GBR 101+102 10:40~11:00 AI and radiomics in glioma  Philipp Vollmuth(Heidelberg University Hospital Germany) 
±³À°½Ã°£ 03-24 GBR 101+102 11:00~11:20 Artificial intelligence in neuro-oncology: Promising applications and challenges  Sung Soo Ahn(Severance Hospital Yonsei University) 
±³À°½Ã°£ 03-24 GBR 101+102 11:20~11:40 Perfusion MRI analysis for radiogenomics of gliomas: Deep-learning approach  Kyu Sung Choi(Seoul National University Hospital) 
±³À°½Ã°£ 03-24 GBR 103 10:40~11:00 New players in immune microenvironment for glioma management  Michael Lim(Stanford University USA) 
±³À°½Ã°£ 03-24 GBR 103 11:00~11:20 T cell Heterogeniety in glioma microenvironment  Eui-Cheol Shin(Korea Advanced Institute of Science and Technology (KAIST)) 
±³À°½Ã°£ 03-24 GBR 103 11:20~11:40 Crosstalk between immune and molecuar microenvironent in gliomas  Michael Platten(German Cancer Research Center (DKFZ) & Mannheim University Hospital Germany) 
±³À°½Ã°£ 03-24 GBR 104+105 10:40~11:10 Ongoing Clinical Trials for Recurrent High Grade Gliomas: How Can We Make a Breakthrough?  David A. Reardon(Harvard Medical School USA) 
±³À°½Ã°£ 03-24 GBR 104+105 11:10~11:40 Challenges of Neuro-Oncology Clinical Trials and Future Perspectives  Michael Weller(University Hospital Zurich Switzerland) 
±³À°½Ã°£ 03-24 GBR 101+102 11:40~12:10 Pediatric type diffuse glioma-Low grade glioma  Cynthia Hawkins(The Hospital for Sick Children Canada) 
±³À°½Ã°£ 03-24 GBR 101+102 12:10~12:40 Pediatric type diffuse glioma-high grade glioma  Guido Reifenberger(Heinrich-Heine-University Germany) 
±³À°½Ã°£ 03-24 GBR 103 11:40~12:00 Understanding response to treatment in glioma  Roel Verhaak(Jackson Laboratory for Genomic Medicine USA) 
±³À°½Ã°£ 03-24 GBR 103 12:00~12:20 Evolution of gliomas: epigenetic aspect  Houtan Noushmehr(Hermelin Brain Tumor Center & Henry Ford Health System USA) 
±³À°½Ã°£ 03-24 GBR 103 12:20~12:40 Evolution of Glioblastoma: Proteogenomics aspects in longitudinal study  Jong Bae Park(National Cancer Center) 
±³À°½Ã°£ 03-24 GBR 104+105 11:40~12:00 Updates & ongoing NRG/RTOG trials for brain metastases and primary CNS tumors  Minesh P Mehta(Miami Cancer Institute USA) 
±³À°½Ã°£ 03-24 GBR 104+105 12:00~12:20 Updates & ongoing EORTC trials for primary brain tumors  Pim J. French(Erasmus MC Cancer Institute The Netherlands) 
±³À°½Ã°£ 03-24 GBR 104+105 12:20~12:40 Updates and ongoing trials of heavy ion therapy for brain tumors  Jiade J. Lu(Shanghai Proton and Heavy Ion Center China) 
È޽Ġ03-24  12:40~13:40 Lunch Break  () 
±³À°½Ã°£ 03-24 GBR 101+102 13:40~14:00 Extent of resection threshold in malignant gliomas  Nader Sanai(Barrow Neurological Institute USA) 
±³À°½Ã°£ 03-24 GBR 101+102 14:00~14:20 Role of supratotal resection in gliomas  Jong Hee Chang(Severance Hospital Yonsei University) 
±³À°½Ã°£ 03-24 GBR 101+102 14:20~14:40 Role of surgery in Lower-grade Gliomas  Lorenzo Bello(University of Milan Italy) 
±³À°½Ã°£ 03-24 GBR 103 13:40~14:00 Spatial & Temporal Surgical Sampling of Glioma: Challenges & Opportunities  Colin Watts(University of Birmingham UK) 
±³À°½Ã°£ 03-24 GBR 103 14:00~14:20 Molecular signature of glioblastoma origin site and origin cells  Seok-Gu Kang(Severance Hospital Yonsei University) 
±³À°½Ã°£ 03-24 GBR 103 14:20~14:40 Resting state quiescence and lifelong neurogenesis in mouse or Possible cell of origin in other brain tumors  Luis F. Parada(Memorial Sloan Kettering Cancer Center USA) 
±³À°½Ã°£ 03-24 GBR 104+105 13:40~14:00 Systemic Treatment for Recurrent High Grade Gliomas: Current Standard  Matthias Preusser(Medical University of Vienna Austria) 
±³À°½Ã°£ 03-24 GBR 104+105 14:00~14:20 Precision Medicine and Targeted Therapy for High Grade Glioma  Mark Rosenthal(Peter MacCallum Cancer Centre Australia) 
±³À°½Ã°£ 03-24 GBR 104+105 14:20~14:40 Updates on Immunotherapy for High Grade Glioma  Antonio Omuro(Yale Brain Tumor Center Yale University USA) 
±³À°½Ã°£ 03-24 GBR 101+102 14:40~15:00 White matter anatomy of the brain  Christophe Destrieux(Tours University France) 
±³À°½Ã°£ 03-24 GBR 101+102 15:00~15:20 A connectomic atlas of the human cerebrum  Michael E. Sughrue(Prince of Wales Private Hospital Australia) 
±³À°½Ã°£ 03-24 GBR 101+102 15:20~15:40 Clinical management of gliomas at the functional regions of brain  Chuanlu Jiang(Harbin Medical University China) 
±³À°½Ã°£ 03-24 GBR 103 14:40~15:00 Tumor microtubes: drivers of glioma progression and resistance  Frank Winkler(Heidelberg University and German Cancer Research Center Germany) 
±³À°½Ã°£ 03-24 GBR 103 15:00~15:20 Electrical and synaptic integration of glioma into neural circuit  Michelle Monje(Stanford University USA) 
±³À°½Ã°£ 03-24 GBR 103 15:20~15:40 Cellular quiescence and resistance in Glioblastoma  Lachlan Harris(The Francis Crick Institute UK) 
±³À°½Ã°£ 03-24 GBR 104+105 14:40~15:00 Management of Side Effects of Cytotoxic Chemotherapy in Brain Tumor  Joo Han Lim(Inha University) 
±³À°½Ã°£ 03-24 GBR 104+105 15:00~15:20 Adverse Events of Antiangiogenic Agents and Other Targeted Agents  Wolfgang Wick(University of Heidelberg Germany) 
±³À°½Ã°£ 03-24 GBR 104+105 15:20~15:40 Immune Related Adverse Events  John F de Groot(University of California San Francisco USA) 
±³À°½Ã°£ 03-24 GBR 101+102 15:50~16:10 Virtual Reality for Neurosurgery  Walter Jean(Lehigh Valley Health Network USA) 
È޽Ġ03-24  15:40~16:00 Break  () 
±³À°½Ã°£ 03-24 GBR 101+102 16:10~16:30 Smart Cyber Operating Theater for brain tumor surgery  Yoshihiro Muragaki(Tokyo Women) 
±³À°½Ã°£ 03-24 GBR 101+102 16:30~16:50 High-field Intraoperative MRI and Glioma Surgery  Michael R Chicoine(Washington University School of Medicine USA) 
±³À°½Ã°£ 03-24 GBR 103 16:00~16:30 Elucidating the resistance to immunotherapy in brain tumors using a humanized microbiome mouse model  Braden C. McFarland(University of Alabama at Birmingham USA) 
±³À°½Ã°£ 03-24 GBR 103 16:30~17:00 Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice  Cristina Limatola(Sapienza University Italy) 
±³À°½Ã°£ 03-24 GBR 104+105 16:00~16:20 Why should we assess quality of life in adult brain tumor patients?  Zarnie Lwin(University of Queensland Australia) 
±³À°½Ã°£ 03-24 GBR 104+105 16:20~16:40 Fear of cancer recurrence in adult CNS patients  Phyllis Butow(The University of Sydney Australia) 
±³À°½Ã°£ 03-24 GBR 104+105 16:40~17:00 Later and long-term effect of pediatric brain tumor treatment  Jung Lee(Seoul National University) 
±³À°½Ã°£ 03-24 GBR 101+102 17:00~17:20 Cranial nerve preservation in the endoscopic skull base surgery  Won Kim(University of California Los Angeles USA) 
±³À°½Ã°£ 03-24 GBR 101+102 17:20~17:40 How to manage the complication of endoscopic skull base surgery  Masahiro Shin(University of Tokyo Japan) 
±³À°½Ã°£ 03-24 GBR 101+102 17:40~18:00 Optical Principles of Fluorescence-Guidedendoscopic tumor surgery  John Lee(University of Pennsylvania USA) 
±³À°½Ã°£ 03-24 GBR 103 17:00~17:20 Identification and clinical implications of MET alterations in brain tumor  Tao Jiang(Capital Medical University China) 
±³À°½Ã°£ 03-24 GBR 103 17:20~17:40 RNA interference in glioma biology  Adelheid Woehrer(Institute of Neurology Medical University of Vienna Austria) 
±³À°½Ã°£ 03-24 GBR 103 17:40~18:00 Glioma epigenetics: glioma and histone remodeling  MinGyu Lee(MD Anderson Cancer Center USA) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022 ´ëÇѽŰæÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ ¹× Á¦6Â÷ ¼¼°è½Å°æÁ¾¾çÇÐȸ Çмú´ëȸ (1ÀÏÂ÷) : 2022-03-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ ´ë±¸ ¡¤ °æºÏ ÁöºÎȸ Á¦1Â÷ ÇмúÁý´ãȸ : 2022-03-24
´ÙÀ½±Û (¿Â¶óÀÎ) Á¦65ȸ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ¼¼¹Ì³ª : 2022-03-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20985 ¼­¿ï 2024 Á¦ 13ȸ ´ëÇѺñ´¢»ý½Ä±âÅëÇÕ±â´ÉÀÇÇבּ¸È¸ Çмú´ëȸ : 2024-06-22 0 30 2024-06-14
20984 Ãæ³² 2024³â ´ëÇÑ°í°üÀýÇÐȸ Áø·áÁöħ ½ÉÆ÷Áö¿ò : 2024-06-22 0 25 2024-06-14
20983 ±¤ÁÖ Á¦24ȸ ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ È£³²Áöȸ Á¤±âÇмú´ëȸ : 2024-06-22 0 29 2024-06-14
20982 °æ±â ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Annual Academy for young oncologists(2ÀÏÂ÷) : 2024-06-22 0 31 2024-06-14
20981 °æºÏ ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦43Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-22 0 31 2024-06-14
20980 °æ³² 2024 ÁøÁÖ½ÃÀÇ»çȸ »ó¹Ý±â Àǻ翬¼ö±³À° : 2024-06-22 0 14 2024-06-14
20979 °æ±â °¡Å縯´ëÇб³ÀÇÁ¤ºÎ¼º¸ðº´¿ø Á¦ 8Â÷ °æ±âºÏºÎ °³¿øÀǸ¦ À§ÇÑ Çмú´ëȸ : 2024-06-22 0 25 2024-06-14
20978 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ½ÉÆ÷Áö¾ö : 2024-06-22 0 20 2024-06-14
20977 ¼­¿ï ´ëÇÑÈĵÎÀ½¼º¾ð¾îÀÇÇÐȸ 11ȸ °ø¿¬¹ß¼º ½ÉÆ÷Áö¾ö : 2024-06-22 0 22 2024-06-14
20976 ¼­¿ï (¿Â¶óÀÎ)2024³â ´ëÇѳëÀÎÀçÈ°ÀÇÇÐȸ ³ëÀÎÀçÈ°Àü¹®°¡ ½ÉÈ­°úÁ¤ : 2024-06-22 0 25 2024-06-14
20975 ÀüºÏ Á¦75Â÷ Çѱ¹ÃéÀå¿Ü°úÇÐȸ Çмú´ëȸ : 2024-06-22 0 14 2024-06-14
20974 Á¦ÁÖ ´ëÇѳúÇ÷°ü³»Ä¡·áÀÇÇÐȸ The 18th Annual Summer Conference on Endovascular Neurosurgical Therapy (ASCENT 2024) 2ÀÏÂ÷ : 2024-06-22 0 22 2024-06-14
20973 ±¤ÁÖ 2024³â »ó¹Ý±â ±¤ÁÖ±¤¿ª½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-22 0 52 2024-06-14
20972 ¼­¿ï 2024³â ´ëÇÑÀÇ·áÁ¤º¸ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-21 0 20 2024-06-14
20971 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2024 SNUH Rare Disease Workshop : 2024-06-21 0 19 2024-06-14
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷